Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study

UK Medical Research Council, National Institute for Health and Care Research Exeter Biomedical Research Centre, and EFSD/Novo Nordisk.

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Europe
Published
2025-11-27
DOI
https://doi.org/10.1016/j.lanepe.2025.101547
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study

Sebastian J. Vollmer, Lauren R. Rodgers, Katherine Young, John Dennis et al.
The Lancet Regional Health - Europe
Diabetes Treatment and Management
article

Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study

Sebastian J. Vollmer, Lauren R. Rodgers, Katherine Young, John Dennis, Pedro Cardoso, Christopher Jennison, Angus G. Jones, Laura M. Güdemann, Trevelyan J. McKinley, Alastair Gray, William Henley, Rury R. Holman, Salim Janmohamed, Andrew Tym Hattersley, Andrew A. Farmer, Nicky Britten, Christopher Hyde, Robert S. Lindsay, Naveed A. Sattar, Catherine Angwin, Bilal Akhter Mateen, William Hamilton, Ewan R. Pearson, Rhian Hopkins, Mark Walker, Timothy J. McDonald, Olorunsola F. Agbaje, Beverley M. Shields, Michael N. Weedon, Stephen Gough, Kennedy Cruickshank
article en

Abstract

UK Medical Research Council, National Institute for Health and Care Research Exeter Biomedical Research Centre, and EFSD/Novo Nordisk.

The Lancet Regional Health - EuropeVol. 61
Birmingham City University (GB), University of Exeter (GB), Churchill Hospital (GB), Ninewells Hospital (GB), University of Oxford (GB), Oxford Centre for Diabetes, Endocrinology and Metabolism (GB), NIHR Exeter Clinical Research Facility (GB), University of Glasgow (GB), University of Birmingham (GB)
Wellcome Trust, National Institute for Health and Care Research, Department of Health and Social Care, European Foundation for the Study of Diabetes, Novo Nordisk, Medical Research Council, NIHR Exeter Clinical Research Facility
Openalex Percentile: Top 51%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.